Erich M Sturgis Selected Research

Squamous Cell Carcinoma (Epidermoid Carcinoma)

12/2019	A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer.
1/2019	Incorporation of Cervista Human Papillomavirus 16/18 Assay Into Algorithms for Classifying Human Papillomavirus Status in Formalin-Fixed, Paraffin-Embedded Head and Neck Squamous Carcinoma Specimens.
1/2018	TGFβ1 Genetic Variants Predict Clinical Outcomes of HPV-Positive Oropharyngeal Cancer Patients after Definitive Radiotherapy.
10/2017	Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
1/2017	Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx.
1/2017	Association between miRNA-binding site polymorphisms in double-strand break repair genes and risk of recurrence in patients with squamous cell carcinomas of the non-oropharynx.
1/2017	E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx.
1/2017	A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma.
11/2016	Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).
6/2016	Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erich M Sturgis Research Topics

Disease

127	Neoplasms (Cancer) 01/2022 - 05/2002
57	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2002
43	Oropharyngeal Neoplasms 01/2022 - 07/2005
32	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2019 - 09/2003
25	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 01/2004
15	Carcinoma (Carcinomatosis) 01/2021 - 03/2005
15	Carcinogenesis 01/2017 - 10/2004
12	Neoplasm Metastasis (Metastasis) 11/2018 - 04/2003
10	Thyroid Neoplasms (Thyroid Cancer) 12/2021 - 07/2004
9	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 05/2002
7	Infections 01/2021 - 03/2010
6	Laryngeal Neoplasms (Laryngeal Cancer) 01/2019 - 08/2008
5	Xerostomia 01/2022 - 01/2018
5	Pathologic Constriction (Stenosis) 01/2021 - 10/2009
5	Deglutition Disorders (Dysphagia) 01/2021 - 01/2016
5	Sarcoma (Soft Tissue Sarcoma) 05/2013 - 04/2003
4	Hemangiosarcoma (Angiosarcoma) 01/2022 - 04/2003
4	Mouth Neoplasms (Oral Cancer) 01/2022 - 09/2002
4	Inflammation (Inflammations) 07/2013 - 03/2010
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2021 - 01/2018
3	Pneumonia (Pneumonitis) 01/2016 - 01/2011
3	Tongue Neoplasms (Tongue Neoplasm) 01/2014 - 05/2009
2	Fatigue 01/2022 - 10/2015
2	Disease Progression 01/2022 - 06/2015
2	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2021 - 01/2021
2	Liver Diseases (Liver Disease) 01/2021 - 12/2019
2	Lymphopenia (Lymphocytopenia) 01/2020 - 12/2017
2	Anaplastic Thyroid Carcinoma 01/2019 - 11/2018
2	Margins of Excision 07/2017 - 04/2003
2	Osteoradionecrosis 01/2016 - 10/2009
2	Mucositis 01/2016 - 10/2009
2	Overweight 06/2014 - 09/2011
2	Marijuana Use 01/2014 - 05/2009
2	Papillary Thyroid Cancer 02/2012 - 01/2012
2	Xeroderma Pigmentosum (Kaposi's Disease) 01/2012 - 08/2008
2	Wounds and Injuries (Trauma) 11/2010 - 02/2008

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2005
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2004
16	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2007
15	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2010
13	Codon (Codons)IBA 08/2012 - 09/2002
11	ORALIT (ORS)IBA 01/2019 - 11/2008
10	Biological ProductsIBA 01/2022 - 09/2003
10	SmokeIBA 01/2020 - 03/2005
9	3' Untranslated Regions (3' UTR)IBA 12/2019 - 09/2005
9	CarcinogensIBA 05/2014 - 01/2002
8	Oncogene Proteins (Oncogene Protein)IBA 12/2019 - 04/2008
7	AntibodiesIBA 01/2021 - 07/2003
5	tetraethylpyrazine (TEP)IBA 01/2021 - 01/2011
5	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2014 - 03/2011
5	arginylarginine (Arg-Arg)IBA 01/2012 - 09/2002
5	Benzo(a)pyreneIBA 08/2008 - 06/2007
5	Epoxy Compounds (Epoxides)IBA 08/2008 - 06/2007
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
4	Messenger RNA (mRNA)IBA 01/2019 - 04/2013
4	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2017 - 04/2011
4	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA 08/2008 - 06/2007
4	MutagensIBA 06/2008 - 05/2007
4	Folic Acid (Vitamin M)FDA LinkGeneric 08/2005 - 12/2004
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 12/2021 - 12/2012
3	Pharmaceutical PreparationsIBA 01/2021 - 11/2018
3	ParaffinIBA 01/2019 - 01/2010
3	Caspase 3 (Caspase-3)IBA 04/2013 - 01/2008
3	DNA AdductsIBA 01/2010 - 06/2007
3	Glutathione Transferase (Glutathione S-Transferase)IBA 05/2009 - 07/2006
2	pembrolizumabIBA 01/2022 - 11/2018
2	Papillomavirus Vaccines (HPV Vaccines)IBA 05/2020 - 01/2018
2	VaccinesIBA 05/2020 - 01/2013
2	Hepatitis C AntibodiesIBA 12/2019 - 01/2016
2	Cetuximab (Erbitux)FDA Link 01/2019 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 07/2017
2	AntigensIBA 12/2017 - 07/2015
2	E2F Transcription FactorsIBA 01/2017 - 10/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2014 - 07/2013
2	Tumor Biomarkers (Tumor Markers)IBA 04/2013 - 09/2012
2	arginylprolineIBA 08/2012 - 09/2002
2	GuanineIBA 10/2010 - 06/2010
2	Adenine FDA LinkGeneric 10/2010 - 06/2010
2	CytosineIBA 10/2010 - 06/2010

Therapy/Procedure

57	Radiotherapy 01/2022 - 04/2003
26	Therapeutics 01/2021 - 04/2003
9	Proton Therapy 12/2021 - 01/2016
7	Drug Therapy (Chemotherapy) 01/2021 - 04/2003
7	Neck Dissection (Radical Neck Dissection) 02/2020 - 12/2007
6	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022 - 01/2016
6	Aftercare (After-Treatment) 01/2021 - 05/2009
5	Laryngectomy 01/2021 - 12/2007
5	Gastrostomy 01/2021 - 07/2005
4	Chemoradiotherapy 01/2022 - 10/2010
4	Punctures 01/2021 - 01/2011
4	Enteral Nutrition (Feeding, Tube) 01/2017 - 10/2009
3	Secondary Prevention 10/2021 - 09/2008
3	Free Tissue Flaps 01/2021 - 02/2008
3	Neoadjuvant Therapy 05/2008 - 09/2005
3	Adjuvant Radiotherapy 08/2004 - 04/2003
2	Blood Transfusion (Blood Transfusions) 01/2021 - 12/2019
2	Re-Irradiation 11/2020 - 10/2017
2	Thyroidectomy 02/2020 - 05/2014
2	Induction Chemotherapy 09/2012 - 05/2009
2	Combined Modality Therapy 05/2011 - 04/2003